Evidence map›Paper›PMID 17369054›Full record

ArticleNeuroImage2007

In vivo axonal transport rates decrease in a mouse model of Alzheimer's disease.

Karen Dell Brown Smith, Verena Kallhoff, Hui Zheng, Robia G Pautler

Open access · greenAbstract read
In one paragraph

Article in NeuroImage, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 147 citations in OpenAlex.

  1. Review
  2. Review
  3. Frontiers in neuroscience · 2023
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Karen Dell Brown SmithDepartment of Molecular Physiology and Biophysics, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.
Verena Kallhoff
Hui Zheng
Robia G Pautler
Baylor College of Medicine · US

Funding

Knockin Mouse Models of Alzheimers DiseaseR01AG020670 · NIA · BAYLOR COLLEGE OF MEDICINE · PI Hui Zheng · 2002 to 2026
$9.1M
Pathophysiology of APP in vivo.R01AG032051 · NIA · BAYLOR COLLEGE OF MEDICINE · PI ZHENG, HUI · 2008 to 2017
$3.5M
Presenilins in tumorigenesis and neurodegenerationR01NS040039 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI ZHENG, HUI · 2000 to 2007
$2.6M
Neuroimaging Biomarkers in Mouse Models of ADR01AG029977 · NIA · BAYLOR COLLEGE OF MEDICINE · PI PAUTLER, ROBIA G · 2008 to 2012
$1.5M
Role of APP in Synaptic RegulationR01AG033467 · NIA · BAYLOR COLLEGE OF MEDICINE · PI ZHENG, HUI · 2009 to 2013
$1.5M
MRI Determination of Axonal Transport Rates in Mouse CNSR21NS051274 · NINDS · BAYLOR COLLEGE OF MEDICINE · PI PAUTLER, ROBIA G · 2005 to 2006
$342k
NIA NIH HHS R01 AG020670NIA NIH HHS R01 AG029977NIA NIH HHS R01 AG032051NIA NIH HHS R01 AG033467NIA NIH HHS R01AG20670NINDS NIH HHS 1R21NS051274-01NINDS NIH HHS R01 NS040039NINDS NIH HHS R01NS40039NINDS NIH HHS R21 NS051274
6 · The paper itself

Abstract

Axonopathy is a pronounced attribute of many neurodegenerative diseases. In Alzheimer's disease (AD), axonal swellings and degeneration are prevalent and may contribute to the symptoms of AD senile dementia. Current limitations in identifying the contribution of axonal damage to AD include the inability to detect when this damage occurs in relation to other identifiers of AD because of the invasiveness of existing methods. To overcome this, we further developed the MRI methodology Manganese Enhanced MRI (MEMRI) to assess in vivo axonal transport rates. Prior to amyloid-beta (Abeta) deposition, the axonal transport rates in the Tg2576 mouse model of AD were normal. As Abeta levels increased and before plaque formation, we observed a significant decrease in axonal transport rates of the Tg2576 mice compared to controls. After plaque formation, the decline in the transport rate in the Tg2576 mice became even more pronounced. These data indicate that in vivo axonal transport rates decrease prior to plaque formation in the Tg2576 mouse model of AD.

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAnimalsAxonal TransportBlotting, WesternBody TemperatureColchicineData Interpretation, StatisticalKineticsMagnetic Resonance ImagingManganeseMiceMice, Inbred C57BLPlaque, AmyloidAmyloid beta-PeptidesColchicineManganese

Identifiers

PMID17369054
PMCPMC2063432
OpenAlexW1993943874

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.